Synthesis of Two Glucagon Antagonists: Receptor Binding, Adenylate Cyclase, and Effects on Blood Plasma Glucose Levels

Beat Gysin, David G. Johnson, Dev Trivedi, Victor J. Hruby

Research output: Contribution to journalArticlepeer-review

24 Scopus citations

Abstract

In diabetes mellitus, hyperglycemia is often associated with elevated levels of glucagon in the blood. This suggests that glucagon (1) is a contributing factor in the metabolic abnormalities of diabetes mellitus. A glucagon-receptor antagonist would provide direct evidence for glucagon's role in diabetes mellitus. On the basis of careful consideration of conformational, arnphiphilic and structural factors, we have synthesized two new glucagon analogues with antagonist biological activities by using solid-phase methodology. These two new analogues, [Asp3,D-Phe4,Ser5,Lys17>18,Glu21]glucagon (2) and [D-Phe4,Tyr5,3,5-I2-Tyr10,Arg12,Lys17'I8,Glu21]glucagon (3), had IC50values 5.4% and 50% those of glucagon, respectively, and showed no measurable adenylate cyclase activity. When tested in normal rats, 2 lowered plasma glucose levels and suppressed glucagon-mediated hyperglycemia 105 ±8%, back to basal levels. Analogue 3, which lowered the basal adenylate cyclase activity in rat liver plasma membranes, increased plasma glucose levels at very high concentration in vivo and inhibited glucagon-mediated hyperglycemia in normal rats by 50%. However, neither of the new glucagon antagonists lowered the plasma glucose levels of diabetic animals. The data would suggest these new glucagon-receptor antagonists may have two actions: (a) in normal rats they can act as standard glucagon-receptor inhibitors of glucagon-mediated glycogenolysis; (b) in diabetic rats, however, because of the low levels of glycogen in the liver, the antagonists apparently have little or no antagonist effect or enhancement on glucagon-mediated glucose production.

Original languageEnglish (US)
Pages (from-to)1409-1415
Number of pages7
JournalJournal of Medicinal Chemistry
Volume30
Issue number8
DOIs
StatePublished - Aug 1 1987

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery

Fingerprint Dive into the research topics of 'Synthesis of Two Glucagon Antagonists: Receptor Binding, Adenylate Cyclase, and Effects on Blood Plasma Glucose Levels'. Together they form a unique fingerprint.

Cite this